CompletedPhase 4

Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

Mexico26 participantsStarted 2005-10

Plain-language summary

This trial is conducted in North America. The aim of this trial is to investigate the efficacy of biphasic insulin aspart 30 in subjects with type 2 diabetes not achieving glycaemic targets on OADs (oral anti-diabetic drugs).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type 2 diabetes mellitus for at least 12 months * HbA1c between 7.5-14.5% (inclusive) at screening * Insulin naïve * An antidiabetic regimen that has been stable for at least 3 months prior to screening * An antidiabetic regimen that includes a minimum of 2 OADs Exclusion Criteria: * Use of any insulin preparations within the past 6 months * Active proliferative retinopathy or maculopathy requiring treatment within 6 months prior to screening

What they're measuring

Percentage of subjects achieving HbA1c (glycosylated haemoglobin A1c) below 7.0%

Trial details

NCT IDNCT01486862

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-07

View on ClinicalTrials.gov More Diabetes trials